17hon MSN
Merck KGaA is paying more than double for this gene-silencing biotech, which is soaring 125%
Silence Therapeutics stock surges as Merck KGaA agrees to acquire the RNA drugmaker for over $1 billion.
Learn when TIDE-based Sanger sequencing can replace NGS for measuring on-target gene editing efficiency in regulated ...
Dublin, Oct. 20, 2026 (GLOBE NEWSWIRE) -- "Human Neuregulin Molecular Reagent Market in Germany" has been added to ResearchAndMarkets.com's offering. The global human neuregulin molecular reagent ...
The most common side effects seen with ZL-1310 plus Tecentriq in the study were anemia (42.2%), nausea (26.7%), ...
Dublin, Oct. (GLOBE NEWSWIRE) -- "Bioconjugation Market in the Netherlands" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is expected to grow at a CAGR of 9.5% ...
She runs the Medical Research and Education Institute at Moscow State University ...
From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...
18h
Healthcare is catching the rotation out of AI. Josh Brown's list includes two names that can benefit
It moves, and the list is where we see it first. The Best Stocks in the Market list is built by the market, and this week the market is saying healthcare. My friend Adam Parker at Trivariate Research ...
Oak Ridge National Laboratory’s BioMADE membership connects biological research, materials development and manufacturing ...
Mr. Astley-Sparke brings more than two decades of biotech leadership, having scaled several highly innovative transatlantic companies, ...
What is going on or being built near the southeast parking lot at IBM? There's been an array of large pieces of construction ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results